Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 31, 2017 Market Just Got More Crowded as Regeneron, Sanofi's New RA Drug Wins FDA Approval May 22, 2017 Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO May 14, 2017
